NCT01474174View on ClinicalTrials.gov

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Central Nervous System Neoplasm
Interventions
BIOLOGICAL

trivalent influenza vaccine

Given IM

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01474174 - Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors | Biotech Hunter | Biotech Hunter